ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ENSC vs PTN // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Ensysce Biosciences Inc. (NASDAQ) VS. Palatin Technologies Inc. (NASDAQ) • 15-METRIC TALLY: ENSC 2 — PTN 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENSC VS. PTN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ENSC PTN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -2.80% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 1/9 +1.00 ENSC /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 40.2 25.3 +14.94 ENSC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $8.5M $8.8M -$258.0K PTN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ENSC REV PTN REV ENSC GROSS % PTN GROSS % ENSC FCF PTN FCF
FY 2025 $5.1M $0 — — -$7.9M -$21.3M
FY 2024 $5.2M $4.5M — 97.8% -$7.5M -$31.5M
FY 2023 $2.2M $4.9M — — -$10.8M -$29.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENSC // BETA —
PTN // BETA —